Christopher Bunka - 15 May 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Reporting relationship: Director
Issuer ticker: LEXX
Reported as of: 15 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 May 2025, 17:39:39 UTC
Prior SEC filing: 10 Jan 2025
Next SEC filing: 30 Jul 2025
Source filing: View source filing
Reporting owner signature: /Christopher Bunka/

Key filing fact

Christopher Bunka filed Form 4 for Lexaria Bioscience Corp. (LEXX) on 16 May 2025.

Key facts

This page summarizes Christopher Bunka's Form 4 filing for Lexaria Bioscience Corp. (LEXX).
1 reported transaction and 7 derivative rows are listed below.
Accepted by SEC: 16 May 2025, 17:39.

Change

Previous filing in this sequence was filed on 10 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001103780 Primary reporting owner

BUNKA CHRISTOPHER

Relationship: Director
Address: SUITE 100, 740 MCCURDY ROAD, KELOWNA, BRITISH COLUMBIA, CANADA
Signature: /Christopher Bunka/
Signature date: 16 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LEXX holding

common shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 373,543
Date: 15 May 2025
Ownership: Direct
Footnotes: F1

LEXX holding

common shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 254,412
Date: 15 May 2025
Ownership: Private Holding Company

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LEXX transaction Derivative

Stock Options

Award

Transaction value: $0
Shares: +11,000
Change %: +6.3%
Price: $0.000000
Shares after: 184,834
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 11,000
Exercise price: $1.04

LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 26,000
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 26,000
Exercise price: $3.00

LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 49,334
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 23,334
Exercise price: $3.00

LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 64,334
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 15,000
Exercise price: $3.00

LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 94,334
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 30,000
Exercise price: $2.91

LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 124,334
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 30,000
Exercise price: $1.15

LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 173,834
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 49,500
Exercise price: $2.36

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

100,000 common shares were issued as a restricted stock award that is subject to escrow provisions until July 7, 2025.